Search

Search Results

• 

  Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

  Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

  16-05-2024

  https://doi.org/10.4081/btvb.2024.115

  697

  PDF: 219
• 

  Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

  Bianca Clerici, Mariangela Scavone, Gian Marco Podda

  20-06-2024

  https://doi.org/10.4081/btvb.2024.127

  1893

  PDF: 512
• 

  Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

  Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò

  23-05-2022

  https://doi.org/10.4081/btvb.2022.23

  3739

  PDF: 266
• 

  Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

  Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga

  28-06-2023

  https://doi.org/10.4081/btvb.2023.72

  571

  PDF: 192
• 

  “Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers

  Giuseppe Auteri, Laura Ricci, Nicola Vianelli, Barbara Lovrencic

  13-03-2025

  https://doi.org/10.4081/btvb.2025.161

  308

  PDF: 122

  Appendix A: 31

  Appendix B: 38
• 

  Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

  Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

  17-10-2022

  https://doi.org/10.4081/btvb.2022.40

  2389

  PDF: 226
• 

  Venous thromboembolism and mortality in patients with hematological malignancies

  Kristen M. Sanfilippo, Tzu-Fei Wang

  16-05-2024

  https://doi.org/10.4081/btvb.2024.119

  673

  PDF: 241
• 

  Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

  Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

  16-05-2024

  https://doi.org/10.4081/btvb.2024.118

  797

  PDF: 310
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  1456

  PDF: 312
• 

  How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

  Anna Falanga, Hugo Ten Cate, Bianca Rocca

  27-01-2023

  https://doi.org/10.4081/btvb.2023.60

  676

  PDF: 300